Back to MW MARSHALL WACE, LLP

APYXAPYX
Showing 3 of 7 quarters

Position history for MWMARSHALL WACE, LLP's holdings in APYX MEDICAL CORPORATION

MARSHALL WACE, LLP holds 236,466 shares of APYX (APYX MEDICAL CORPORATION), worth $1.1M as of 2026-Q2. The position was increased (+282.4% shares). APYX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$1.1M

Current Shares

236,466

Total Value Change

+$684,167

Total Shares Change

+128,591

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
236,466
+282.4%
$1.1M0.0%$4.49
41
2026-Q1
Decreased
61,836
-42.7%
$228,1740.0%$3.17
0
2025-Q4
New
107,875
-
$377,5650.0%$3.44
33

Other major holders of APYX: Steward Partners Investment Advisory, LLC, BNP PARIBAS FINANCIAL MARKETS, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used